Thailand · Delayed Price · Currency is THB AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of THB 12.28 trillion. The enterprise value is 14.25 trillion.
| Market Cap | 12.28T |
| Enterprise Value | 14.25T |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Jan 16, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 73.76% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 92.12 and the forward PE ratio is 15.28.
| PE Ratio | 92.12 |
| Forward PE | 15.28 |
| PS Ratio | 6.37 |
| PB Ratio | -149.80 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 106.88 |
| EV / Sales | 7.49 |
| EV / EBITDA | 15.56 |
| EV / EBIT | 21.58 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.34 |
| Debt / FCF | n/a |
| Interest Coverage | 8.08 |
Financial Efficiency
Return on equity (ROE) is 1,106.67% and return on invested capital (ROIC) is 22.47%.
| Return on Equity (ROE) | 1,106.67% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 22.47% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 35.07M |
| Profits Per Employee | 2.42M |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AbbVie has paid 74.55 billion in taxes.
| Income Tax | 74.55B |
| Effective Tax Rate | 35.83% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 7.09 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.97 |
| Average Volume (20 Days) | 84,129 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.42 |
Income Statement
In the last 12 months, AbbVie had revenue of THB 1.93 trillion and earned 133.28 billion in profits. Earnings per share was 74.43.
| Revenue | 1.93T |
| Gross Profit | 1.38T |
| Operating Income | 669.03B |
| Pretax Income | 208.05B |
| Net Income | 133.28B |
| EBITDA | 927.71B |
| EBIT | 669.03B |
| Earnings Per Share (EPS) | 74.43 |
Balance Sheet
The company has 178.85 billion in cash and 2.17 trillion in debt, with a net cash position of -1,992.44 billion.
| Cash & Cash Equivalents | 178.85B |
| Total Debt | 2.17T |
| Net Cash | -1,992.44B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -81.96B |
| Book Value Per Share | -47.14 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.64%, with operating and profit margins of 34.69% and 6.91%.
| Gross Margin | 71.64% |
| Operating Margin | 34.69% |
| Pretax Margin | 10.79% |
| Profit Margin | 6.91% |
| EBITDA Margin | 48.10% |
| EBIT Margin | 34.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 1.30%.
| Dividend Per Share | 0.09 |
| Dividend Yield | 1.30% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | 1.08% |
| Earnings Yield | 1.09% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |